Linking Tau PET to Medial Temporal Lobe Subregions with High Resolution MRI
Enrolling By Invitation
60-99 years
All
Phase
N/A
150 participants needed
Brief description of study
The goal of this research is to collect Tau PET imaging in cognitively normal older adults and
patients with Mild Cognitive Impairment (MCI) in the NACC study, to
determine relationship to clinical, cognitive, and other biomarker data.
Findings from this study will likely provide insight into the
mechanisms and distinctions of age-related cognitive decline and that of
Alzheimer's disease.
Only those participants enrolled in the NACC cohort (protocol 068200) who have received a consensus conference designation
of Cognitively Normal or MCI, are eligible to participate in this protocol.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: cognitive impairment, alzheimers
-
Age: Between 60 Years - 99 Years
-
Gender: All
Updated on
01 Aug 2024.
Study ID: 833864
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu
For cancer trials contact EmergingMed: 1-855-216-0098 or PennCancerTrials@emergingmend.com
